Contraception for the perimenopausal woman
review
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This paper reviews reproductive issues during perimenopause, focusing on pregnancy prevention and symptom relief interventions to inform clinical counseling for women in menopause transition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Perimenopause, or the menopause transition, is a time in a woman's life that bridges her reproductive years through to the non-surgical cessation of ovulation, or menopause. For many women this time is one of changes: changes in gynecological issues, onset of symptoms not experienced in her youth and increasing risks for adverse medical conditions. Despite the clear changes that occur for many women during this time, one critical issue is frequently ignored, namely, that, until the onset of menopause, she is exposed to pregnancy if sexually active, and pregnancy for older reproductive women is fraught with considerable increases in morbidity and mortality compared to younger women. This paper will present a review of the reproductive issues of the perimenopause and interventions geared to preventing pregnancy and relieving menopause-related symptoms. As counseling remains a critical aspect in empowering women to make informed choices about their health care, this paper will present current evidence that will help clinicians provide accurate reproductive counseling to women in the menopause transition.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Impact of estrogen type on cardiovascular safety of combined oral contraceptives 2016
- Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS 2009
- The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives 2011
Cited by (1)
References (55)
- Impact of estrogen type on cardiovascular safety of combined oral contraceptives via openalex
- Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS via openalex
- The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives via openalex
- W1684740056 via openalex
- W1907235146 via openalex
- W1966099207 via openalex
- W1967396619 via openalex
- W1983181264 via openalex
- W1991174173 via openalex
- W1995127183 via openalex
- W2005115577 via openalex
- W2011962210 via openalex
- W2015434610 via openalex
- W2017506407 via openalex
- W2022674398 via openalex
- W2026108022 via openalex
- W2045197658 via openalex
- W2045701013 via openalex
- W2049035283 via openalex
- W2052257363 via openalex
- W2055072006 via openalex
- W2065547060 via openalex
- W2068796004 via openalex
- W2070137667 via openalex
- W2071133410 via openalex
- W2094606328 via openalex
- W2109004499 via openalex
- W2123191014 via openalex
- W2142599245 via openalex
- W2147405232 via openalex
- W2148601805 via openalex
- W2152605904 via openalex
- W2156027325 via openalex
- W2157028280 via openalex
- W2160156071 via openalex
- W2163114984 via openalex
- W2167428807 via openalex
- W2190911845 via openalex
- W2260626412 via openalex
- W2272590651 via openalex
- W2276162234 via openalex
- W2289252471 via openalex
- W2290784319 via openalex
- W2301968847 via openalex
- W2311882922 via openalex
- W2416184576 via openalex
- W2765711695 via openalex
- W3141386680 via openalex
- W4231103938 via openalex
- W4232664472 via openalex
- W4234744513 via openalex
- W880930254 via openalex
- W4250107476 via openalex
- W1534368881 via openalex
- W1574745824 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK